• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞间相互作用与阿司匹林加重的呼吸道疾病。

Cellular interactions in aspirin-exacerbated respiratory disease.

机构信息

Department of Medicine, University of California San Diego.

Veterans Affairs San Diego Healthcare System, La Jolla, California, USA.

出版信息

Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):65-70. doi: 10.1097/ACI.0000000000000712.

DOI:10.1097/ACI.0000000000000712
PMID:33306487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7769923/
Abstract

PURPOSE OF REVIEW

The purpose of this review is to summarize the complex cellular interactions of aspirin-exacerbated respiratory disease (AERD) and how these interactions promote pathogenic mechanisms of AERD.

RECENT FINDINGS

In addition to characteristic changes in eicosanoid levels, recent studies have identified increases in alarmin cytokines (IL-33, thymic stromal lymphopoietin) as well as activated innate lymphoid and plasma cell populations in samples from AERD patients.

SUMMARY

Patients with AERD typically demonstrate high levels of proinflammatory eicosanoids including cysteinyl leukotrienes (CysLTs) and prostaglandin D2 (PGD2) and hyporesponsiveness to prostaglandin E2 (PGE2). CysLTs are released by mast cells, eosinophils, and adherent platelets and promote epithelial release of IL-33, which activates mast cells and group 2 innate lymphoid cells (ILC2s) in concert with CysLTs. TSLP induces PGD2 release from mast cells which activates and recruits eosinophils, basophils, Th2 cells, and ILC2s via CRTH2. In turn, ILC2s and other cell types produce Th2 cytokines IL-4, IL-5, and IL-13 that, along with CysLTs and PGD2, promote bronchoconstriction, eosinophilic tissue inflammation, and mucus production.

摘要

目的综述

本文旨在总结阿司匹林加重性呼吸系统疾病(AERD)中复杂的细胞间相互作用,以及这些相互作用如何促进 AERD 的发病机制。

最新发现

除了花生四烯酸代谢产物水平的特征性变化外,最近的研究还发现 AERD 患者样本中警报素细胞因子(IL-33、胸腺基质淋巴细胞生成素)和活化的固有淋巴细胞和浆细胞群体增加。

总结

AERD 患者通常表现出高水平的促炎类花生酸,包括半胱氨酰白三烯(CysLTs)和前列腺素 D2(PGD2),并且对前列腺素 E2(PGE2)的反应降低。CysLTs 由肥大细胞、嗜酸性粒细胞和黏附血小板释放,并促进上皮细胞释放 IL-33,与 CysLTs 一起激活肥大细胞和 2 型固有淋巴细胞(ILC2)。TSLP 诱导肥大细胞释放 PGD2,激活并募集嗜酸性粒细胞、嗜碱性粒细胞、Th2 细胞和 ILC2 通过 CRTH2。反过来,ILC2 和其他细胞类型产生 Th2 细胞因子 IL-4、IL-5 和 IL-13,与 CysLTs 和 PGD2 一起促进支气管收缩、嗜酸性粒细胞组织炎症和黏液产生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b7/7769923/e2a77aed3ac8/nihms-1652112-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b7/7769923/e2a77aed3ac8/nihms-1652112-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b7/7769923/e2a77aed3ac8/nihms-1652112-f0001.jpg

相似文献

1
Cellular interactions in aspirin-exacerbated respiratory disease.细胞间相互作用与阿司匹林加重的呼吸道疾病。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):65-70. doi: 10.1097/ACI.0000000000000712.
2
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.胸腺基质淋巴细胞生成素控制阿司匹林加重性呼吸疾病患者中前列腺素D2的生成。
J Allergy Clin Immunol. 2016 May;137(5):1566-1576.e5. doi: 10.1016/j.jaci.2015.10.020. Epub 2015 Dec 12.
3
Association of interleukin-25 levels with development of aspirin induced respiratory diseases.白细胞介素-25水平与阿司匹林诱发的呼吸道疾病发生的关联。
Respir Med. 2017 Feb;123:71-78. doi: 10.1016/j.rmed.2016.11.020. Epub 2016 Nov 24.
4
Prostaglandin E2 in NSAID-exacerbated respiratory disease: protection against cysteinyl leukotrienes and group 2 innate lymphoid cells.前列腺素 E2 在 NSAID 加重的呼吸系统疾病中的作用:对半胱氨酰白三烯和 2 型固有淋巴细胞的保护作用。
Curr Opin Allergy Clin Immunol. 2019 Feb;19(1):38-45. doi: 10.1097/ACI.0000000000000498.
5
Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.阿司匹林加重性呼吸疾病涉及半胱氨酰白三烯驱动的白细胞介素-33介导的肥大细胞激活途径。
J Immunol. 2015 Oct 15;195(8):3537-45. doi: 10.4049/jimmunol.1500905. Epub 2015 Sep 4.
6
Cysteinyl leukotriene E activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D and epithelial cytokines.半胱氨酰白三烯E激活人类2型固有淋巴细胞并增强前列腺素D和上皮细胞因子的作用。
J Allergy Clin Immunol. 2017 Oct;140(4):1090-1100.e11. doi: 10.1016/j.jaci.2016.12.958. Epub 2017 Jan 20.
7
Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.2 型半胱氨酰白三烯受体驱动 IL-33 依赖性 2 型免疫病理学和阿司匹林敏感性。
J Immunol. 2018 Feb 1;200(3):915-927. doi: 10.4049/jimmunol.1700603. Epub 2017 Dec 27.
8
Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis.2型固有淋巴细胞在阿司匹林加重性呼吸道疾病发病机制中的作用。
Am J Rhinol Allergy. 2018 Jan 1;32(1):7-11. doi: 10.2500/ajra.2018.32.4498.
9
Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease.先天免疫细胞失调导致阿司匹林加重的呼吸道疾病中的炎症和疾病。
J Allergy Clin Immunol. 2021 Aug;148(2):309-318. doi: 10.1016/j.jaci.2021.06.016.
10
Aspirin-exacerbated respiratory disease.阿司匹林加重的呼吸道疾病。
Curr Opin Immunol. 2020 Oct;66:9-13. doi: 10.1016/j.coi.2020.02.006. Epub 2020 Apr 13.

引用本文的文献

1
Low Prostaglandin E but High Prostaglandin D, a Paradoxical Dissociation in Arachidonic Acid Metabolism in Aspirin-Exacerbated Airway Disease: Role of Airway Epithelium.前列腺素E水平低但前列腺素D水平高,阿司匹林加重性气道疾病中花生四烯酸代谢的矛盾解离:气道上皮的作用
J Clin Med. 2024 Dec 5;13(23):7416. doi: 10.3390/jcm13237416.
2
Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment.非甾体抗炎药加重的呼吸系统疾病:分子机制、管理与治疗
Front Allergy. 2024 Nov 27;5:1462985. doi: 10.3389/falgy.2024.1462985. eCollection 2024.
3
Cysteinyl Leukotrienes in Allergic Inflammation.
过敏炎症中的半胱氨酰白三烯
Annu Rev Pathol. 2025 Jan;20(1):115-141. doi: 10.1146/annurev-pathmechdis-111523-023509. Epub 2025 Jan 2.
4
Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related disease.抗白细胞介素-4受体抗体治疗阿司匹林加重性呼吸系统疾病合并IgG4相关性疾病患者的长期疗效
Allergy Asthma Clin Immunol. 2023 Aug 5;19(1):67. doi: 10.1186/s13223-023-00825-z.
5
Lower serum 15-HETE level predicts nasal ILC2 accumulation during COX-1 inhibition in AERD.血清 15-HETE 水平降低预示着 AERD 中 COX-1 抑制时鼻 ILC2 的积累。
J Allergy Clin Immunol. 2023 Nov;152(5):1330-1335.e1. doi: 10.1016/j.jaci.2023.06.028. Epub 2023 Aug 3.
6
Pathomechanisms of AERD-Recent Advances.阿司匹林性呼吸道疾病的发病机制——最新进展
Front Allergy. 2021 Sep 10;2:734733. doi: 10.3389/falgy.2021.734733. eCollection 2021.